The Role of Cilostazol and Inflammation in Cognitive Impairment After Ischemic Stroke

Purpose: The aim of this study is to examine the potential effect cilostazol and inflammation on cognitive impairment after stroke in an Asian population. Methods: Forty-five patients with ischemic using were enrolled as group 45 aspirin or clopidogrel control group. Neuropsychiatric assessments administered at start 6 months. Multiple logistic regression analysis was used estimate association between change use. Macrophage polarization assessed flow cytometry 7 patients. Results: There a significantly higher number peripheral arterial occlusive disease No significant differences observed groups. M1 macrophage subset increment patient having declined change. Conclusion: Cilostazol did not make difference stroke. may indicate post decline. Due limited subjects, these findings should be examined further large-scale randomized clinical trials.